(Q56960106)

1

0 references

Brian F. Tack

2

0 references

Paul B. McCray

3

0 references

Michael J. Welsh

American Journal of Physiology - Lung Cellular and Molecular Physiology

4

0 references

publication date

November 2000

0 references

published in

0 references

volume

279

0 references

issue

5

0 references

page(s)

L799-L805

0 references

cites work

Antimicrobial Synergism in the Therapy of Gram-Negative Rod Bacteremia

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

Soluble proteins of bronchopulmonary secretions from patients with cystic fibrosis, asthma, and bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

Cloning, organization, and expression of the bioluminescence genes of Xenorhabdus luminescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

Antimicrobial defensin peptides of the human ocular surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

Elemental composition of human airway surface fluid in healthy and diseased airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

Human nasal respiratory secretions and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

Distribution of secretory leukoprotease inhibitor in the human nasal airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

Production of beta-defensins by human airway epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

Activity of abundant antimicrobials of the human airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

Human beta-defensin-1: an antimicrobial peptide of urogenital tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799

Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.2000.279.5.L799